Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world.
  • Posted by Richard Head and Jennifer Redfearn
  • May 15, 2018
  • Awards, News

Janssen & Research Partnership win prestigious BHBIA Best Business Impact award

Janssen & Research Partnership win prestigious BHBIA Best Business Impact award

We are delighted to announce that Janssen and Research Partnership have won the BOBI (Best of Business Intelligence) Award in the Best Business Impact category at the BHBIA annual conference in London for our collaborative market research and consultancy work.

read more »

Research Partnership and Janssen are 2017-18 BOBI Awards finalists

Research Partnership and Janssen are 2017-18 BOBI Awards finalists

We are delighted to announce that an entry submitted by Research Partnership with Janssen has been selected as a finalist in the Best Business Impact category at this year’s BOBI (Best of Business Intelligence) Awards for our combined work in helping to reverse the fortunes of one of their established products, which up until recently had been suffering from declining market growth in the UK.

read more »

  • Posted by Julie Denny
  • March 27, 2014
  • News

Janssen publishes diabetes research conducted by Research Partnership

Janssen publishes diabetes research conducted by Research Partnership

Janssen have published a report and call to action called “Diabetes in the Downturn” incorporating market research conducted by Research Partnership.

Janssen have published a report and call to action called “Diabetes in the Downturn” incorporating market research conducted by Research Partnership. The report provides an in-depth look at the impact of the recent economic downturn on diabetes management in six European countries. It offers perspectives from both patients and general practitioners and reveals the additional stresses associated with trying to manage type 2 diabetes during a time of global fiscal pressure.

read more »